INOVIO Pharmaceuticals
NEWS ALERT

FDA Accepts for Review INOVIO’s BLA for INO-3107 for the Treatment of Adults with Recurrent Respiratory Papillomatosis (RRP)

Press Releases

INOVIO Announces Pricing of $17.5 Million Public Offering

Posted on April 2, 2026

INOVIO Announces Pricing of $17.5 Million Public Offering

Posted on April 2, 2026

INOVIO Announces Proposed Public Offering

Posted on April 1, 2026

INOVIO Announces Proposed Public Offering

Posted on April 1, 2026

INOVIO to Participate in Upcoming Scientific Conference

Posted on April 1, 2026

INOVIO to Participate in Upcoming Scientific Conference

Posted on April 1, 2026

INOVIO Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights

Posted on March 12, 2026

INOVIO Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights

Posted on March 12, 2026

INOVIO to Participate in Upcoming Scientific Conferences

Posted on March 9, 2026

INOVIO to Participate in Upcoming Scientific Conferences

Posted on March 9, 2026

SUBSCRIBE FOR UPDATES FROM INOVIO
Register to receive email alerts for INOVIO press releases

© Copyright 2026 INOVIO Pharmaceuticals. All rights reserved.